Published in Front Cell Dev Biol on August 26, 2016
REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS. J Bacteriol (1961) 41.67
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Introduction to NF-kappaB: players, pathways, perspectives. Oncogene (2006) 7.78
Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev (2003) 6.57
The binding of antibiotics to serum proteins. Br J Pharmacol Chemother (1965) 5.04
Preparing for the next pandemic. N Engl J Med (2005) 4.65
Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis (2003) 2.06
An interferon-gamma-related cytokine storm in SARS patients. J Med Virol (2005) 1.83
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control (2006) 1.75
How honey kills bacteria. FASEB J (2010) 1.71
Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat (2010) 1.66
Comparison of the antimicrobial activity of Ulmo honey from Chile and Manuka honey against methicillin-resistant Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. BMC Complement Altern Med (2010) 1.58
The pharmacophore of short cationic antibacterial peptides. J Med Chem (2003) 1.35
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents (2011) 1.28
Host defense peptides: front-line immunomodulators. Trends Immunol (2014) 1.26
Small cationic antimicrobial peptides delocalize peripheral membrane proteins. Proc Natl Acad Sci U S A (2014) 1.22
Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides. Int J Med Microbiol (2009) 1.05
Daptomycin: a review of properties, clinical use, drug delivery and resistance. Mini Rev Med Chem (2012) 0.98
Novel approaches are needed to develop tomorrow's antibacterial therapies. Am J Respir Crit Care Med (2015) 0.95
Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies. Antimicrob Agents Chemother (2011) 0.95
Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care (2007) 0.94
Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs. Biophys J (2007) 0.94
Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J Med Chem (2004) 0.88
Solid-phase synthesis, characterization, and antibacterial activities of metallocene-peptide bioconjugates. ChemMedChem (2006) 0.88
Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups. Beilstein J Org Chem (2012) 0.83
Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care (2007) 0.82
Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues. ACS Comb Sci (2013) 0.81
Sequential insertion of three different organometallics into a versatile building block containing a PNA backbone. Dalton Trans (2010) 0.81
Melittin peptides exhibit different activity on different cells and model membranes. Amino Acids (2014) 0.81
Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain. ACS Med Chem Lett (2012) 0.80
Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert Opin Investig Drugs (2015) 0.79
Influence of lipidation on the mode of action of a small RW-rich antimicrobial peptide. Biochim Biophys Acta (2015) 0.78
Healing outcomes of MRSA-infected wounds with a protocol combining Oakin dressing with elements of the de-escalation theory. J Wound Care (2014) 0.77
Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence. Int J Antimicrob Agents (2015) 0.77
Influence of the Multivalency of Ultrashort Arg-Trp-Based Antimicrobial Peptides (AMP) on Their Antibacterial Activity. ChemMedChem (2015) 0.77
Influence of metallocene substitution on the antibacterial activity of multivalent peptide conjugates. J Inorg Biochem (2016) 0.77